Study/year | Mean age (y) statin/ non-statin (mean ± SD) | Male sex (%) statin/non-statin | Need for MV or ICU admission | Severity of illness statin/non-statin (mean ± SD) | Mortality statin/non-statin | Length of hospital stay statin/non-statin | New development of severe sepsis | |
---|---|---|---|---|---|---|---|---|
 |  |  |  |  | In-hospital mortality | 28-day mortality |  |  |
Novak V et al.[17]/2009 | 66.0 ± 17.2/72.7 ± 13.8 | 35.7/39.0 | 3/42 vs 5/41 | APACHE II score (11.2 ± 4.3/8.9 ± 4.8) | 0/42 vs 0/41 | NA | 4 days (IQR 3 to 6)/4 days (IQR 2 to 6) | 2/42 vs 2/41 |
Kruger PS et al.[18]/2011 | 68.2 ± 12.7/68.5 ± 11.9 | 64.0/65.0 | 13/75 vs 11/75 | NA | 6/75 vs 4/75 | NA | 7 days (IQR 4 to 12)/6 days (IQR 4 to 11) | NA |
Patel JM et al.[19]/2012 | 62.8 ± 21.2/64.0 ± 15.6 | 51.0/51.0 | 0/49 vs 2/51 | APACHE II score (11.8 ± 5.6/11.9 ± 6.0) | NA | 2/49 vs 2/51 | 5 days (IQR 3 to 13)/6 days (IQR 4 to 12) | 2/49 vs 12/51 |
Kruger P et al.[20]/2013 | 58 (44 to 67)/64 (50 to 75)* | 59.0 /65.0 | 123/123 vs 127/127 | APACHE II score (22.1 ± 7.7/23.5 ± 7.8) | 16/123 vs 23/127 | 12/123 vs 22/127 | 18.3 days (IQR 11.0 to 38.7)/22.7 days (IQR 12.4 to 37.0) | NA |
Papazian L et al.[21]/2013 | 60.0 ± 16.0/59.0 ± 17.0 | 73.0/77.0 | 146/146 vs 138/138 | SOFA score (7.2 ± 3.6/6.7 ± 2.9) | 43/146 vs 38/138 | 31/146 vs 21/138 | 37 days (IQR 21 to 59)/35 days (IQR 22 to 62) | NA |